Motus GI and Memorial Hermann Hospital Partner to Improve its Colonoscopy Efficiencies
FORT LAUDERDALE, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"),...
News
COVID-19 Vaccine Capable Air Transportation System Patent Awarded to Reflect Scientific for its Liquid Nitrogen Temperature-controlled Cooling and Freezing Systems
OREM, Utah, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Capital Senior Living Corporation Further Reduces Debt and Improves Cash Position with Sale of Ohio Community
Company is retained by new owner to manage communityDALLAS, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the...
Jushi Holdings Inc. Acquires Remaining Equity Ownership Interests of Dalitso LLC, the Company’s Virginia-Based Pharmaceutical Processor Permit Holder
Jushi Holdings Inc. Increases Equity Ownership Interest in Dalitso LLC to 100% BOCA RATON, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE)...
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the U.S. Food...
Orphazyme establishes U.S. headquarters in Chicago as the company prepares for commercialization
Orphazyme A/SInvestor news ...
Inovalon to Participate in a Virtual Fireside Chat at the Guggenheim Digital Health Summit on December 8, 2020
BOWIE, Md, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare,...
Adagene Announces Expansion of Leadership Team to Support Strategic Growth
Hua Gong, M.D., Ph.D., appointed Chief Operating Officer and Head of Precision MedicineJC Xu, M.D., Ph.D., appointed Chief Scientific OfficerQinghai...
KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
CELEBRATION, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery...
Kolab Project Launches Ice Cream Cake Dried Flower with Safari Flower Co., a New Premium Craft Grower Collaboration
Kolab Project x Safari Ice Cream Cake Kolab Project x Safari Ice Cream Cake Kolab Project Safari Packaging Kolab Project...
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company...
TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib in Patients with Chronic Lymphocytic Leukemia Who Are Intolerant to Prior BTK or PI3K Inhibitor Therapy in Blood
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of data from...
Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-GM1 Clinical Trial in Patients with GM1 Gangliosidosis
On-track to report topline results from low-dose cohort by end of 2020NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02,...
Osmotica Pharmaceuticals plc Announces Agreement to Settle Patent Litigation with Adamas
Adamas to acquire global rights to OSMOLEX ER® for $7.5 million Company to focus on maximizing commercial opportunity for Upneeq™...
Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus
- Topline data expected in first half of 2021 - STAMFORD, Conn., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics,...
Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors
CRANBURY, N.J., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment of Michael...
Immatics Announces Third Quarter 2020 Financial Results and Business Update
ACTengine® IMA200 clinical trial series continues scaling globally; initial analysis for patients in ACTengine® dose escalation is on track for...
Todos Medical Announces $3.2 Million in Sales for November 2020, a 269% Increase Sequential Month over Month Sales Growth from October 2020
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Dec. 02, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics...
Skylight Health Graduates to OTCQX® Market in the United States
Skylight Health graduates to the highest tier of the OTC Markets offering greater visibility for the Company’s shares and improved...
FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
New data show safety and efficacy of roxadustat in treating anemia secondary to lower-risk myelodysplastic syndromes (MDS) regardless of ring...